BioCentury | Nov 5, 2019
Company News

Management tracks: Santhera, Acadia, Aeglea, Entrada, Kleo, Laboratory for Advanced Medicine, Imago, Glympse and Cognition

...function in neurodegenerative disorders, hired James O’Brien as CFO. He was EVP of finance at Enzo Biochem Inc....
BioCentury | Mar 21, 2017
Distillery Therapeutics

Cancer

...DETAILS: Ruggiero, C. et al. Sci. Signal. ; published online March 7, 2017 doi:10.1126/scisignal.aal2464 CONTACT: Enzo...
BioCentury | Dec 3, 2015
Product R&D

Eyeing fewer needles

...endothelial growth factor (VEGF) receptor. Age-related macular degeneration (AMD) and choroidal neovascularization (CNV) Phase II Enzo Biochem Inc....
BioCentury | Nov 9, 2015
Company News

Affymetrix, Enzo microarrays news

...regarding Enzo’s U.S. Patent No. 7,064,197, covering a nucleic acid array, system and non-porous solid. Enzo...
...its GeneChip microarray, Axiom genotyping and GeneAtlas microarray products. Affymetrix Inc. (NASDAQ:AFFX), Santa Clara, Calif. Enzo Biochem Inc....
BioCentury | Mar 30, 2015
Clinical News

FlowScript HPV E6/E7 regulatory update

...company said the flow cytometry-based multiplex test will be available “in the next few weeks.” Enzo...
BioCentury | Mar 23, 2015
Company News

Enzo, Thermo Fisher genomics news

...Circuit (CAFC) vacated a lower court judgment that Life Technologies Corp .’s sequencing instruments infringed Enzo’s...
...CAFC’s claim construction. Thermo Fisher acquired Life Technologies in February 2014. The district court awarded Enzo...
...patent infringement suit (see BioCentury, Nov. 5, 2012; Aug. 19, 2013 & Jan. 13, 2014). Enzo Biochem Inc....
BioCentury | Nov 24, 2014
Company News

Enzo supply/service news

...alleging that Enzo wrongfully input diagnosis codes into claim forms submitted to CMS for tests Enzo...
...for physicians. The complaint was brought under the Federal and New York False Claims Acts. Enzo Biochem Inc....
BioCentury | Jul 31, 2014
Translation in Brief

Translational tidbits

...some of which were also funded by SBIR grants. Compounds will be sourced primarily from Enzo...
...Spring Harbor, N.Y. Cornell University , Ithaca, N.Y. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Enzo...
BioCentury | Jun 9, 2014
Company News

Enzo management update

Enzo Biochem Inc. (NYSE:ENZ), Farmingdale, N.Y. Business: Autoimmune, Infectious, Supply/Service Hired: James O'Brien as SVP of finance, formerly VP and corporate controller at Actavis plc ; he succeeds Andrew Crescenzo WIR Staff...
BioCentury | May 5, 2014
Company News

Affymetrix, Enzo supply/service news

...Affymetrix will pay Enzo $5.1 million to settle two breach of contract cases in the U.S...
...York. Enzo filed the cases in 2003 and 2004 regarding a 1998 deal in which Enzo...
...granted Affymetrix non-exclusive rights to distribute reagent labeling kits. Affymetrix Inc. (NASDAQ:AFFX), Santa Clara, Calif. Enzo Biochem Inc....
Items per page:
1 - 10 of 208
BioCentury | Nov 5, 2019
Company News

Management tracks: Santhera, Acadia, Aeglea, Entrada, Kleo, Laboratory for Advanced Medicine, Imago, Glympse and Cognition

...function in neurodegenerative disorders, hired James O’Brien as CFO. He was EVP of finance at Enzo Biochem Inc....
BioCentury | Mar 21, 2017
Distillery Therapeutics

Cancer

...DETAILS: Ruggiero, C. et al. Sci. Signal. ; published online March 7, 2017 doi:10.1126/scisignal.aal2464 CONTACT: Enzo...
BioCentury | Dec 3, 2015
Product R&D

Eyeing fewer needles

...endothelial growth factor (VEGF) receptor. Age-related macular degeneration (AMD) and choroidal neovascularization (CNV) Phase II Enzo Biochem Inc....
BioCentury | Nov 9, 2015
Company News

Affymetrix, Enzo microarrays news

...regarding Enzo’s U.S. Patent No. 7,064,197, covering a nucleic acid array, system and non-porous solid. Enzo...
...its GeneChip microarray, Axiom genotyping and GeneAtlas microarray products. Affymetrix Inc. (NASDAQ:AFFX), Santa Clara, Calif. Enzo Biochem Inc....
BioCentury | Mar 30, 2015
Clinical News

FlowScript HPV E6/E7 regulatory update

...company said the flow cytometry-based multiplex test will be available “in the next few weeks.” Enzo...
BioCentury | Mar 23, 2015
Company News

Enzo, Thermo Fisher genomics news

...Circuit (CAFC) vacated a lower court judgment that Life Technologies Corp .’s sequencing instruments infringed Enzo’s...
...CAFC’s claim construction. Thermo Fisher acquired Life Technologies in February 2014. The district court awarded Enzo...
...patent infringement suit (see BioCentury, Nov. 5, 2012; Aug. 19, 2013 & Jan. 13, 2014). Enzo Biochem Inc....
BioCentury | Nov 24, 2014
Company News

Enzo supply/service news

...alleging that Enzo wrongfully input diagnosis codes into claim forms submitted to CMS for tests Enzo...
...for physicians. The complaint was brought under the Federal and New York False Claims Acts. Enzo Biochem Inc....
BioCentury | Jul 31, 2014
Translation in Brief

Translational tidbits

...some of which were also funded by SBIR grants. Compounds will be sourced primarily from Enzo...
...Spring Harbor, N.Y. Cornell University , Ithaca, N.Y. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Enzo...
BioCentury | Jun 9, 2014
Company News

Enzo management update

Enzo Biochem Inc. (NYSE:ENZ), Farmingdale, N.Y. Business: Autoimmune, Infectious, Supply/Service Hired: James O'Brien as SVP of finance, formerly VP and corporate controller at Actavis plc ; he succeeds Andrew Crescenzo WIR Staff...
BioCentury | May 5, 2014
Company News

Affymetrix, Enzo supply/service news

...Affymetrix will pay Enzo $5.1 million to settle two breach of contract cases in the U.S...
...York. Enzo filed the cases in 2003 and 2004 regarding a 1998 deal in which Enzo...
...granted Affymetrix non-exclusive rights to distribute reagent labeling kits. Affymetrix Inc. (NASDAQ:AFFX), Santa Clara, Calif. Enzo Biochem Inc....
Items per page:
1 - 10 of 208